Neuphoria Therapeutics (NEUP) Leases (2024 - 2025)
Neuphoria Therapeutics (NEUP) has disclosed Leases for 2 consecutive years, with $75219.0 as the latest value for Q3 2025.
- Quarterly Leases fell 61.9% to $75219.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $75219.0 through Sep 2025, down 61.9% year-over-year, with the annual reading at $102612.0 for FY2025, N/A changed from the prior year.
- Leases for Q3 2025 was $75219.0 at Neuphoria Therapeutics, down from $102612.0 in the prior quarter.
- The five-year high for Leases was $197447.0 in Q3 2024, with the low at $75219.0 in Q3 2025.